BeStock  

Haleon HLN

US equityMarket cap rank #525Drug Manufacturers - Specialty & Generic
$9.07 +$0.02 (+0.22%)
Market closed · Nov 22, 5:30 am ET · Last extended-hours $9.07 0.00%
Open$9.11
Prev close$9.05
Day range$9.07 – $9.17
Volume17.96M
Market cap$39.76B
P/E (TTM)19.1
Dividend yield2.09%
Founded2021
CEOMr. Brian James McNamara
Employees24,535
HeadquartersWeybridge, United Kingdom of Great Britain and Northern Ireland (the)
Websitewww.haleon.com

Revenue per employee

$440.1K$444.3K$448.4K$452.5KDec '19Dec '20Dec '25

24,524 employees as of 2025/FY. Revenue per employee is total revenue divided by headcount — a rough productivity gauge, not a per-worker pay figure.

Management team

Brian James McNamara Chief Executive Officer and Director
Total comp. $8,230,000.00 · As of 12 Mar 2026
Background

Mr. Brian McNamara brings extensive experience in consumer healthcare, product supply and brand marketing gained through senior leadership roles across major global organisations. This, combined with his experience in leading growth in large regions, provides him with the skillset required to inspire and lead the Group. Other significant appointments: The Consumer Goods Forum (Board Member), Mondelez International, Inc. (Non-Executive Director) Previous roles: GSK plc (CEO of the Consumer Healthcare Business), Novartis AG (OTC Division Head and a member of the Executive Committee), Procter & Gamble (Product Supply and Marketing)

Dawn Allen Director and Chief Financial Officer
Total comp. $3,056,000.00 · As of 12 Mar 2026
Background

Ms. Dawn Allen was appointed to the Board on 1 November 2024. Dawn brings extensive financial leadership experience in consumer goods. Her wealth of commercial and international experience is valuable to the Board. She is a member of the Institute of Chartered Accountants of England and Wales. Other significant appointments: ITV plc (Non-Executive Director and member of the Audit & Risk Committee). Previous roles: Tate & Lyle (Chief Financial Officer), Mars Inc. (various country, region, divisional VP CEO roles, most recent being VP and Global CFO Mars Transformation), Tasty Bite Eatables (Non-Executive Director), Ernst & Young (Senior Auditor) .

Manvinder Singh Banga Chairman of the Board
Total comp. $153,000.00 · As of 12 Mar 2026
Background

With over 30 years of leadership experience, primarily within the global consumer goods industry, Vindi has held a range of senior executive roles. His expertise is further enriched by a portfolio of Chair and non-executive directorships across various sectors, in public and private capital markets, providing him with a broad and balanced perspective on governance and cross-industry dynamics, enabling him to provide the Board with valuable leadership. Prior to being appointed Chair of Haleon, Vindi held the role of Senior Independent Director. Other significant appointments: CD&R LLP (Partner), UK Government Investments (Chair), Imperial College London (Chair of the Council), The Economist Group (Non-Executive Director). Previous roles: GSK plc (Senior Independent Director), Marks & Spencer plc (Senior Independent Director), Unilever plc (various roles, most recent being President of the Global Foods, Home and Personal Care business), Confederation of British Industry (CBI) (Non-Executive Director), Thomson Reuters Corp (Non-Executive Director)

Alan James Stewart Senior Independent Director
Total comp. $142,000.00 · As of 12 Mar 2026
Background

Mr. Alan James Stewart was appointed to the Board on 1 September 2024. Alan brings significant corporate finance, accounting and international experience from a wide range of consumer-related industries. He has extensive board and listed company experience. Other significant appointments: Burberry plc (Non-Executive Director and Audit Committee Chair). Previous roles: Diageo plc (Non-Executive Director and Audit Committee Chair), Reckitt Benckiser Group PLC (Non-Executive Director and Remuneration Committee Chair), Games Workshop Group plc (Non-Executive Director and Audit Committee Chair), Tesco plc (Chief Financial Officer), Marks & Spencer plc (Chief Financial Officer). Alan Stewart was appointed as the Senior Independent Director with effect from 01 January 2026.

Tracy Jayne Clarke Independent Director
Total comp. $142,000.00 · As of 12 Mar 2026
Background

Ms. Tracy Jayne Clarke brings a wealth of international banking and financial services expertise to the Board, underpinned by 35 years' diverse experience in the sector. Serving as Chair of the Remuneration Committee for several organisations, she demonstrates a capability to lead discussions on remuneration strategy and policy. Other significant appointments: TP ICAP Group plc (Non-Executive Director and Remuneration Committee Chair), Starling Bank Limited (Senior Independent Director and Remuneration Committee Chair). Previous roles: Standard Chartered Bank (various roles, most recent being Private Bank CEO), Sky plc (Non-Executive Director, Chair of the Remuneration Committee and Big Picture Committee), Eaga plc (Non-Executive Director), Inmarsat plc (Non-Executive Director).

Marie Anne Aymerich Independent Director
Total comp. $136,000.00 · As of 12 Mar 2026
Background

Marie-Anne Aymerich brings extensive experience in leading global brands across multiple categories in the consumer goods and luxury sectors. She has expertise in developing premium product portfolios, notably leading innovations in the oral care industry. Other significant appointments: Pierre Fabre Group (Non-Executive Director), Academy of St Martin in the Fields (Trustee and member of the Nomination Committee) Previous roles: Unilever plc (Global Executive Vice President, Oral Care and Managing Director, Home Care and Personal Care), LVMH Group (Brand General Director - Parfums Christian Dior).

Nancy Avila Independent Director
Total comp. $102,000.00 · As of 12 Mar 2026
Background

Ms. Nancy Avila was appointed to the Board as an Independent Director on 1 September 2024. Nancy brings significant experience leading business transformations with technology, developing new digital channels for growth, modernising operations and addressing regulatory, technology, cyber and financial risk. Most of her career has been spent in technology and business operations across several Fortune 100 companies. Other significant appointments: Analog Devices, Inc. (Chief Information Officer), Comerica Incorporated (Independent Director). Previous roles: McKesson Corporation (Executive Vice President, Chief Information Officer/Chief Technology Officer), Johnson Controls Inc. (Vice President and Chief Information Officer), Abbot Laboratories Inc. (Vice President, Business and Technology Services).

Asmita Dubey Independent Director
Total comp. $102,000.00 · As of 12 Mar 2026
Background

Asmita Dubey brings over 25 years' experience working in consumer businesses. She has extensive experience of working and building joint business partnerships in China. Other significant appointments: L'Oreal (Chief Digital & Marketing Officer and member of Executive Committee) Previous roles: GSK plc (Digital Advisory Board)

Blathnaid Bergin Independent Director
Total comp. $87,400.00 · As of 12 Mar 2026
Background

Ms. Blathnaid Bergin was appointed to the Board on 24 February 2025.Blathnaid brings financial leadership and strategic planning experience from a variety of consumer-facing businesses gained during previous and current executive and nonexecutive positions. She is a qualified chartered accountant and spent most of her career working across Europe, Asia and Australia. Other significant appointments: Sainsburys plc (Chief Financial Officer). Previous roles: Artemis Alpha Investment Trust (Non-Executive Director, Chair of the Audit Committee and Senior Independent Director), Aviva plc (Chief Finance Operations Officer), RSA (various roles, most recent being Group Financial Controller), GE (various roles), Procter & Gamble (Finance Analyst)

Matthew J. Shattock Independent Director
Total comp. $61,000.00 · As of 12 Mar 2026
Background

Matt Shattock joins the Board with substantial experience in innovation, operational leadership, and executive management within the consumer goods and retail sectors. Over the course of his career, he has led major business integrations, revitalised brand portfolios, and driven sustained global growth. Other significant appointments: The Clorox Company (Lead Independent Director), VF Corporation (Non-Executive Director). Previous roles: Domino's Pizza Group plc (Chairman), Beam Suntory Inc (President, Chairman and CEO).

Ed Petter Chief Corporate Affairs Officer
As of 12 Mar 2026
Background

Mr. Ed Petter joined the Executive Team in January 2024 as Chief Corporate Affairs Officer. Prior to Haleon, Ed spent seven years at BT Group plc as Group Corporate Affairs Officer and a member of the Executive Committee. He has previously held leadership roles at Lloyds Banking Group and McDonald's after spending four years working in consultancy at McKinsey & Company and Blue Rubicon.

Carl Haney Chief Research and Development Officer
As of 12 Mar 2026
Background

Carl Haney Chief R&D Officer. Appointed with effect from 1 August 2025.

Kedar Lele President, India Subcontinent
As of 12 Mar 2026
Background

Kedar Lele President, India Subcontinent Appointed with effect from 8 January 2026.

Keith Choy President, Asia Pacific
As of 12 Mar 2026
Background

Mr. Keith Choy has almost 30 years' experience in the consumerpackaged goods and health industries and joined GSK's Consumer Healthcare business in 2019. He was previously President, International Markets for Pfizer Consumer Healthcare. Keith has also held roles at Wyeth Pharmaceutical and Gillette.

Adrian Morris General Counsel
As of 12 Mar 2026
Background

On August 12, 2024, Adrian Morris joined the Executive Team as General Counsel. Adrian has a wealth of expertise across all aspects of legal, regulatory, compliance and governance. He was Group General Counsel at Tesco plc for 11 years and, prior to that, Associate General Counsel at BP plc and Centrica plc.

Bjorn Timelin Head, Strategy
As of 12 Mar 2026
Background

Mr. Bjorn Timelin was Senior Partner at McKinsey & Company specialising in strategic and commercial topics for consumer-facing companies, with clients across the retail, consumer packaged goods, media, and luxury goods sectors. Prior to that he spent four years at Procter & Gamble's beauty care division in the UK and Switzerland.

Filippo Lanzi President, EMEA and LatAm
As of 12 Mar 2026
Background

Mr. Filippo Lanzi joined GSK in 2015 holding leadership roles in south and central eastern Europe prior to becoming APAC Regional Head. He then became Head of EMEA in 2019, prior to leading LatAm. Before this, he worked for Novartis OTC as General Manager in Italy and Greece. Filippo also held positions at Johnson & Johnson and Nestle S.A.

Amanda Mellor Company Secretary
As of 12 Mar 2026
Background

Ms. Amanda Mellor, Company Secretary. Amanda brings extensive experience in company secretarial, corporate governance, investor relations and investment banking. Other appointments: Volution Group plc (Senior Independent Director), GC100 (Executive Committee Member).

Claire Dickson Chief Digital and Technology Officer
As of 12 Mar 2026
Background

Claire Dickson joined the Executive Team in September as Chief Digital and Technology Officer, on 4 September 2024. Claire has more than 25 years' experience working in technology. She was Chief Information Officer at DS Smith where she was accountable for developing and implementing cyber-secure, resilient global operations, while driving growth by enhancing digital and data capabilities across machinery, energy, supply chain and customer experience.

Line De Decker Chief Human Resources Officer
As of 12 Mar 2026
Background

On August 01, 2024, Line de Decker joined the Executive Team as Chief Human Resources Officer. Line has extensive experience navigating complex and regulated organisations, having served as Chief People and Sustainability Officer at Aliaxis, Senior Vice President and Head of Transformation at GSK and held senior HR management positions at GSK and DuPont. She began her career in tax and reward at PwC and UCB.

Namrata P Patel Chief Supply Chain Officer
As of 12 Mar 2026
Background

Ms. Namrata P Patel has extensive global experience in manufacturing and end-to-end supply chain management. She has held senior leadership positions at companies including The Coca-Cola Company, Gillette and Procter & Gamble and currently sits on the board of Oxford Biomedica plc as an Independent Non-Executive Director.

Dr. Dame Vivienne Cox Independent Director
As of 12 Mar 2026
Background

Dr. Vivienne Cox brings extensive experience across multiple industries, particularly in the energy, natural resources and publishing sectors. Her background includes leadership roles in large organisations, focusing on gas, power, renewables and alternative energy. Additionally, she has significant expertise in governance and regulatory affairs. Other significant appointments: Victrex plc (Chair and Nominations Committee Chair), Venterra Group plc (Non-Executive Director). Previous roles: GSK plc (Non-Executive Director and Workforce Engagement Director), BP plc (Executive Vice President and Chief Executive), BG Group plc (Non-Executive Director), Rio Tinto plc (Non-Executive Director), Pearson plc (Senior Independent Director), Vallourec (Chairman of the Supervisory Board), UK Government's Department for International Development (Lead Independent Director).

Nathalie Gerschtein Keraudy President, North America
As of 12 Mar 2026
Background

Nathalie Gerschtein President, North America. Appointed with effect from 1 May 2025.

From SEC filings, via Futu. Compensation is total reported pay for the most recent fiscal year on file, not base salary alone.

Sectors & themes

Discussion

No comments yet — be the first to weigh in on HLN.

Sign in to join the discussion.

Scroll to Top